WuXi AppTec eyes HK after Shanghai success

Pills_230px
By John Loh
19 Sep 2018

WuXi AppTec has filed for a possible $1.9bn dual listing in Hong Kong after making a splash with its Shanghai IPO in May.

The new share sale is being sponsored by Morgan Stanley as the left lead bank together with Huatai Financial and Goldman Sachs, according to a Hong Kong listing application posted on Tuesday.

China-based WuXi AppTec was the largest pharmaceutical research and development services platform in Asia by revenue ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial